ArticleBMC immunology2025
Promoter polymorphisms in the JK*01 W.06 allele associated with the Jk(a +
Article in BMC immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe Kidd blood group system is critical in transfusion medicine, especially for delayed hemolytic reactions. However, the genetic background and molecular mechanisms underlying the weak antigen phenotype remain unclear. This study aimed to elucidate how the JK*01 W.06 allelic variant and its promoter region polymorphisms contribute to reduced Jka antigen expression in the weak antigen phenotype.
methodsSerological techniques and flow cytometry identified 20 Jk(a + w) samples from 800 Han Chinese blood donors. Third-generation sequencing analyzed the JK gene haplotype sequences, quantifying the frequency of the JK*01 W.06 allele and characterizing promoter sequence variations. Dual-luciferase assays assessed the differential transcriptional activities of two distinct promoter sequences, Promoter-A and Promoter-B.
resultsIn Jk(a + w) samples, the frequency of the JK*01 W.06 allele reached 62.5%, significantly higher than that in random samples (34.7%). Analysis of the promoter region sequences revealed that 76.00% of Jk(a + w) samples displayed the Promoter-B polymorphism, whereas Promoter-A was predominant in Jk(a+) samples (76.09%). The dual-luciferase assay demonstrated that Promoter-A exhibited higher transcriptional activity compared to Promoter-B.
conclusionsThis study uncovers the association between the JK*01 W.06 allelic variant and the Jk(a + w) phenotype, highlighting the pivotal role of promoter polymorphisms in potentially influencing the formation of the Jk(a + w) antigen through modulation of transcriptional activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.